Teva Pharmaceutical Industries Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Teva Pharmaceutical Industries Limited with three other
pharmaceutical manufacturers in Middle East:
Saudi Pharmaceutical Industries & Medical Appliances Corporation
of Saudi Arabia
sales of 1.84 billion Saudi Riyals [US$490.99 million]
of which 100%
was Pharmaceutical and Medical Manufacturing),
(182.39 million Israel Shekels [US$50.19 million]
Taro Pharmaceutical Industries Ltd
(3.67 billion Israel Shekels [US$1.01 billion]
Teva Pharmaceutical Industries Limited reported sales of 83.76 billion Israel Shekels (US$23.05 billion)
December of 2016.
increase of 9.7%
versus 2015, when the company's sales were 76.37 billion Israel Shekels.
Sales of Generic Madicines saw an increase
that was more than double the company's growth rate: sales were up
23.6% in 2016, from
37.10 billion Israel Shekels to 45.85 billion Israel Shekels.
Not all segments of Teva Pharmaceutical Industries Limited experienced an increase in sales in 2016:
sales of Other fell 31.0% to 4.74 billion Israel Shekels.